General Biotechnology

Pfizer’s Quest to Stay Ahead of the Pack The drugmaker has been a stable holding in unstable times. Now, though, […]

Can Your Genomics Work Contribute to Biodefense Three years ago, Luis Villarreal, a virologist at the University of California, Irvine,

Biogen/Idec: still a matter of size The merger of Biogen and Idec Pharmaceuticals, announced June 23, is likely to help

The State of Biotechnology Researchers, government officials and industry executives will gather this weekend in Washington for the Biotechnology Industry

Coffee Plants Can Produce Less Caffeine Researchers say they have genetically engineered coffee plants that have 70 percent less caffeine

Pfizer’s Outlook Improves Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the

Pfizer’s Outlook Improves Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the

Schering’s Dr. Feelbetter? Fred Hassan is out to revive the drugmaker. It’s a big job

Schering’s Dr. Feelbetter? Fred Hassan is out to revive the drugmaker. It’s a big job

FDA approves first nasal mist flu vaccine Most people who avoid flu shots because they fear needles will not have